Maybe the tough financial environment here in the United States is causing Sonic Healthcare Ltd., one of this nation’s bigger lab players, to be more interested in overseas lab testing opportunities. On February 18, its CEO, Colin Goldschmidt, M.D., told investors that “We continue to seek out synergistic [laboratory] acquisitions and we believe that Germany
Tag: tripath imaging
It’s a milestone on the path to personalized medicine and an example of how integrated health informatics will give clinicians real-time access to unlimited amounts of medical data. The 1000 Genomes Project announced in recent months that “the world’s largest set of data on human variation” is now available on the Amazon Web Services cloud
In recent months, deficiencies in forensic pathology have made news in both the United States and Canada. In a story released February 5, 2011, on CaliforniaWatch.com, reporter Ryan Gabrielson wrote that “Coroners in Northern California are farming out thousands of cases each year to a private firm whose doctors have dissected the wrong body and
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2006.” Compared to earlier years, 2006 was not transformative for the laboratory industry. But it was an eventful year, particularly influenced by Siemens’ decision to acquire DPC and Bayer Diagnostics, along with the decision by UnitedHealth Group to grant an exclusive national
“Postal Rage” is the term coined to describe the phenomenon of crazed postal workers rampaging through post office facilities shooting at co-workers. In recent days, the nation may have seen its first example of “Patient Rage” in a hospital. On November 20, a patient standing in line to get a prescription from the ambulatory pharmacy
On September 8, Becton, Dickinson & Company (BD) announced that it would acquire TriPath Imaging, Inc. for a purchase price of approximately $350 million. TriPath’s share price has not moved significantly over the past five years, so many shareholders were pushing for change. BD and TriPath have been close collaborators in several areas of molecular
On August 14, AmeriPath, Inc. released its second quarter earnings report. Revenues were $191.7 million, an increase of 35% from $143.6 million posted in second quarter of 2005. These numbers reflect the acquisition of Specialty Laboratories, Inc., which AmeriPath acquired on January 31, 2006. (See TDR, October 3, 2005.) Quarterly revenues for Specialty Laboratories was
CEO SUMMARY: Every second year, THE DARK REPORT releases its list of key trends in anatomic pathology. These trends help shape an understanding about the state of the pathology profession. Our current list includes 11 identifiable trends. This is not an auspicious sign for pathologists who prefer things to remain the same. Eleven distinct trends
PREDICTIVE TESTING FOR RECURRENT BREAST CANCER
LABORATORY TESTS DESIGNED to predict the recurrence of breast cancer are picking up momentum. First to market was Genomic Health Inc.’s Oncotype DX™ breast cancer test. Now TriPath Imaging, Inc. is reporting favorable results from studies of its ProEx Br markers for breast cancer.
Since introducing Oncotype DX in 2004, Genomic
NEW GUIDELINES for cervical cancer screening issued last year are fueling strong growth in the sales of Digene Corporation’s HPV test.
For its fiscal second quarter that ended on December 31, 2004, Digene reported sales of $27.0 million. That’s a 28% increase from Digene’s sales of $21.1 million for its second quarter last year.
HPV test revenues